-Guidelines continue to set Canadian standard for diabetes treatment and management-
TORONTO, April 11, 2013 /CNW/ - Today, the MEDEC Diabetes Committee (MEDEC DC) commends the Canadian Diabetes Association (CDA) for its release of the 2013 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada (CPGs). Every five years since 1998, the CPGs have translated complex and clinical evidence about diabetes into information that healthcare professionals can use and apply in their everyday practices to care for those living with diabetes.
"The MEDEC DC congratulates the CDA on developing its latest set of Guidelines, which will provide medical experts and the public with important information on how to best prevent and manage diabetes in Canada," said Nancy Abbey, Executive Director, MEDEC DC. "Diabetes, in particular type 2 diabetes, is an epidemic across the globe and in Canada, so we welcome the dissemination and adoption of these Guidelines amongst healthcare professionals in an effort to help improve patient outcomes."
The MEDEC DC recognizes the importance of healthcare professional and patient education, and is prepared to collaborate with the CDA, the government and other stakeholders to disseminate more extensive education and training consistent with the recommendations outlined in the CPGs.
The CPG's Expert Committee, made up of leading researchers and healthcare professionals across the country, has developed comprehensive, evidence-based Guidelines which consolidate the best science as it relates to prevention, diagnosis and treatment of the condition from across the globe.
These Guidelines continue to support the importance of self-management practices. According to the Guidelines, "all people with diabetes who are able should be taught how to self-manage their diabetes." MEDEC DC also supports CDA's view of the importance of an individualized approach to self-monitoring of blood glucose (SMBG), where "the recommended frequency of SMBG must be individualized to each person's unique circumstances."1
"Overcoming the current diabetes epidemic will require a concerted and co-ordinated effort by all," said Abbey. "The MEDEC DC wants to play its part in helping to ensure that individuals are self-managing their diabetes most effectively, and making every SMBG test count."
MEDEC is the national association representing the medical technology industry in Canada. MEDEC is the primary source for advocacy, information and education on the medical technology industry for members, the greater healthcare community, industry partners and the general public. Our 150 members are committed to providing safe and innovative medical technologies that enhance quality patient care and advance patient outcomes. The medical technology industry in Canada employs over 35,000 Canadians in close to 1,500 corporate facilities, and has sales of nearly $7 billion per year. We are committed to ensuring that Canada has a strong and vibrant medical technology industry.
About MEDEC DC
The MEDEC Diabetes Committee represents three of the largest manufacturers of blood glucose monitors and test strips in Canada - LifeScan Canada, Roche Diagnostics and Abbott Diabetes Care. The vision of the MEDEC Diabetes Committee is to enhance the lives of individuals living with diabetes through effective self-management of blood glucose levels to optimize care and mitigate or prevent associated short-term and long-term complications.
- Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2013 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Can J Diabetes April 2013;37(suppl 1):S1-212. Available www.guidelines.diabetes.ca (accessed 2013 April 8).
SOURCE: MEDEC DC
For further information:
and interview requests, please contact:
MEDEC Diabetes Committee